Skip to content

Assessing the Impact of Combined TENS and Myofascial Release Therapy for Young Women with Cervicogenic Headaches: A Pilot Study

Evaluating the Efficacy of Transcutaneous Electrical Nerve Stimulation and Myofascial Release among Young Females with Cervicogenic Headache- A pilot feasibility trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077074
Enrollment
20
Registered
2024-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G448- Other specified headache syndromes

Interventions

Intervention1: TENS with MFR: Myofascial Release (MFR): MFR will be applied to the cervical and upper back regions to release muscle tightness and fascial restrictions. The therapist will use sustaine

Sponsors

Galgotias University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Gender: Only females will be included in the study. 2. Age Range: Participants aged between 20-40 years. 3. Diagnosis: Clinically diagnosed with cervicogenic headaches as per standardized diagnostic criteria. 4. Duration of Symptoms: Suffering from cervicogenic headaches for a minimum of 3 months. 5. Pain Intensity: Baseline headache intensity of moderate to severe on the visual analog scale (VAS). 6. Willingness to Participate: Participants must provide written informed consent and agree to adhere to the treatment protocol and follow-up schedule. 7. No Recent Treatment: Participants must not have received any physiotherapy, TENS, or manual therapy interventions in the last 3 months.

Exclusion criteria

Exclusion criteria: 1. Other Headache Types: Exclude participants diagnosed with migraines, tension-type headaches, or any other primary headache disorders. 2. Neck or Spine Surgery: Exclusion of individuals with a history of cervical spine surgery or other surgical interventions. 3. Neurological Disorders: Those with neurological conditions like multiple sclerosis or epilepsy that could influence treatment outcomes. 4. Chronic Pain Syndromes: Exclude individuals diagnosed with fibromyalgia, rheumatoid arthritis, or other systemic musculoskeletal or autoimmune disorders. 5. Pregnancy: Pregnant women or those planning to become pregnant during the study period. 6. Pacemaker or Electrical Implants: Exclude participants with pacemakers or other implanted electrical devices that could interfere with TENS therapy. 7. Psychiatric Conditions: Severe psychiatric disorders (e.g., major depressive disorder, schizophrenia) that might impact the perception of pain or adherence to treatment protocols. 8.

Design outcomes

Primary

MeasureTime frame
Pain Intensity (VAS): Measure reduction in pain severity using the Visual Analog Scale (VAS). Headache Frequency: Track the number of headache episodes per week. Cervical Range of Motion (ROM): Assess improvements in neck mobility. Patient Global Impression of Change (PGIC): Evaluate overall patient-reported improvement after treatment.Timepoint: at baseline

Secondary

MeasureTime frame
Neck Disability Index (NDI): Measure disability caused by neck pain and its impact on daily activities. Quality of Life (SF-36 or EQ-5D): Assess changes in overall physical, emotional, and social well-being. Muscle Tension: Evaluate reduction in muscle tightness through palpation. Psychological Impact (DASS or STAI): Measure changes in anxiety, stress, and depression levels.Timepoint: at baseline

Countries

India

Contacts

Public ContactSoni Singh

galgotias university

Sumera.khan@galgotiasuniversity.edu.in917827777195

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026